Wed.May 29, 2024

article thumbnail

The new menstruation: Girls are getting their periods earlier and less regularly

STAT

Menstruation is a critical indicator of health. Whether and when someone with a uterus gets their period — for the first time, and throughout their life — can reflect not only their reproductive health, but their risk of cardiovascular disease, cancer, miscarriage, and premature death. That also makes menstruation a useful measure of population health.

363
363
article thumbnail

Can robots break the cell therapy bottleneck?

PharmaVoice

A partnership between the cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could bring the manufacturing bottleneck under control, the CEOs said.

275
275
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New obesity drugs are seemingly everywhere. Black Americans feel left out

STAT

STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new weight loss drugs on Black America. Jonathan Gustave was diagnosed with type 2 diabetes last August after decades of struggling with his weight. To help lower his blood sugar levels, his doctor prescribed Ozempic, the diabetes drug that has become wildly popular for its weight loss effects.

Diabetes 362
article thumbnail

FTC request may signal trouble for Novo/Catalent deal

PharmaVoice

As Novo Nordisk aims to secure its manufacturing foothold for GLP-1s, regulators are digging for clues of anti-competitive behavior.

182
182
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Black voices, Black bodies: Life in the age of Ozempic

STAT

STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new weight loss drugs on Black America. When was the last time you thought about your weight?

358
358

More Trending

article thumbnail

STAT+: Health insurers boast to investors about using AI, but they’d rather not talk about it

STAT

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

358
358
article thumbnail

BHF awards £35m funding to nine UK universities for cardiovascular disease

Pharma Times

Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation

125
125
article thumbnail

NIH-funded clinical trials often miss racial, gender diversity enrollment goals, report finds

STAT

WASHINGTON — Clinical trials that the National Institutes of Health funds often enroll fewer Black patients and other underrepresented racial groups than they plan to, according to a study of 30 NIH-funded trials sampled by the HHS Office of Inspector General. Policymakers want to get researchers to enroll a racially representative sample of patients in clinical trials that test whether products work and are safe.

347
347
article thumbnail

Digital therapeutics firm Akili agrees $34 million takeover

pharmaphorum

More consolidation in the digital health sector as Akili agrees a $34m takeover by Virtual Therapeutics, returning to private hands.

119
119
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Wegovy linked to lower risk of alcohol use disorder in real-world study

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. I hope everyone had a restful Memorial Day weekend. I myself was engaged in what my editor calls one of the greatest joys in life — packing up all my belongings, moving two miles, and then unpacking all of my belongings.

article thumbnail

Working for a mature form of genomic medicines

pharmaphorum

In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.

118
118
article thumbnail

STAT+: Akili, maker of a video game to treat ADHD, to be acquired for $34 million

STAT

A month after announcing it was seeking strategic alternatives , Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million. Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD.

Diabetes 325
article thumbnail

Update: MSD confirms $3bn takeover of EyeBio

pharmaphorum

MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular oedema (DME) and neovascular age-related macular degeneration (AMD).

Diabetes 114
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: Clinical lab trade group sues FDA over plan to regulate lab-developed tests

STAT

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests. The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests.

315
315
article thumbnail

Allow pharmacists to amend prescriptions 'within three months', urge MPs

The Pharmacist

Legislation should be changed within the next three months to allow community pharmacists to amend prescriptions in the case of shortages, a parliamentary committee has recommended. ‘Medicine shortages cannot be ignored and left to become the norm,’ a Health and Social Care Committee (HSCC) report, published today, stated. And it warned of a ‘serious risk […] The post Allow pharmacists to amend prescriptions 'within three months', urge MPs appeared first on The Pharmacist.

111
111
article thumbnail

STAT+: Scientists install ‘window’ in the skull to record brain activity using ultrasound

STAT

Researchers may have a new way to watch the brain pulse, thanks to an ultrasound probe and a tiny window in the skull. This acoustically transparent hole allowed a team in California to capture, using functional ultrasound imaging, an extraordinary view of human brain activity of very normal hobbies, according to a study published Wednesday in Science Translational Medicine.

313
313
article thumbnail

AstraZeneca throws its hat into the oral PCSK9 ring

pharmaphorum

AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower cholesterol.

111
111
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Opinion: Saving rural psychiatry services will require higher Medicaid payments

STAT

If there were ever to be an empty bed in the stress unit my psychiatrist dad manages, I’m certain he would admit himself. He runs the only private psychiatric practice in the rural Michigan town of Owosso and is the sole psychiatrist contracted at the local hospital. With approximately 1 in every 10 of the town’s 15,000 residents being a patient in his practice, he shoulders the responsibility for many more patients than most psychiatrists do.

Hospitals 302
article thumbnail

MSD said to be looking at $1.3bn takeover of EyeBio

pharmaphorum

MSD is reported to be on the brink of agreeing a $1.

110
110
article thumbnail

Opinion: The uphill battle to provide noninvasive treatment for fibroids

STAT

If an effective treatment is available for one common disease in men, and that same treatment is available for a different common disease in women, a logical expectation would be that the treatments are equally accessible to men and women. That is not the current reality. The treatment I am talking about is focused ultrasound. It has been approved by the Food and Drug Administration for a range of conditions, including prostate cancer, fibroids, liver tumors, essential tremor and Parkinsonȁ

297
297
article thumbnail

Pharma Pulse 5/29/24: OpenAI Forms New Committee to Evaluate Safety/Security, Proposed FDA Rule Could Limit Pharmacy Compounding & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

STAT+: Biohaven protein-degrader drug falls short of investor expectations in early-study test

STAT

Biohaven Pharmaceuticals said Wednesday that a new type of experimental medicine reduced levels of a disease-causing immune molecule by up to 37% in an early-stage study of human volunteers — a result that the company called “positive” as a proof of concept but that also fell short of investor expectations. The drug, called BHV-1300, belongs to a new class of antibody medicines that shuttle harmful proteins to the liver so they can be removed from the body.

Immunity 282
article thumbnail

Can robots break the cell therapy bottleneck?

BioPharma Dive

A partnership between cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could address manufacturing hurdles, the CEOs said.

106
106
article thumbnail

STAT+: Reports: Looking to expand its pipeline, Merck to buy eye-disease startup EyeBio

STAT

LONDON — Merck is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, according to media reports, as the pharma company looks to diversify its pipeline.   Under the deal, Merck will pay $1.3 billion upfront, with another $1.7 billion if certain milestones are met. The Wall Street Journal first reported the news Tuesday night, and EyeBio’s CEO and board chair outlined in the deal in an interview with the Financial Times published Wednesday.

Diabetes 280
article thumbnail

Celebrities join campaigners in call for cheaper version of ‘gamechanger’ HIV drug for poorer countries

The Guardian - Pharmaceutical Industry

Letter urges US company Gilead Sciences to ‘shape history’ by providing fair access Former world leaders, celebrities and a Nobel prize-winning scientist who helped discover HIV have written to a leading pharmaceutical company to urge it to make a “gamechanger” HIV medicine available to people living outside wealthy countries. The US company Gilead Sciences has been urged to “shape history” by avoiding a repeat of the “horror and shame” of the early years of the Aids pandemic, when 12 million li

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.